Additional file 1 of Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD

Additional file 1: Table 1a. TARGET-IBD Labs/Imaging 24 Weeks Prior to Dose Changes of Biologic Therapy Due to Lack of Effect. Table 1b. TARGET-IBD Labs/Imaging 24 Weeks Prior to Discontinuations of Biologic Therapy Due to Lack of Effect. Table 2a. TARGET-IBD Labs/Imaging within 12 Weeks Before or After Dose Changes of Biologic Therapy Due to Lack of Effect. Table 2b. TARGET-IBD Labs/Imaging within 12 Weeks Before or After Discontinuations of Biologic Therapy Due to Lack of Effect.